Wells Fargo Maintains Equal-Weight on Incyte, Lowers Price Target to $101
Incyte Corporation 0.00%
Incyte Corporation INCY | 97.69 | 0.00% |
Wells Fargo analyst Derek Archila maintains Incyte (NASDAQ:
INCY) with a Equal-Weight and lowers the price target from $107 to $101.
